DKK1 and Alzheimer disease: More importantly, persistent activation of Wnt signaling through Wnt ligands, or inhibition of its negative regulators, such as Dickkopf-1 (DKK-1) and GSK-3β that are hyperactive in disease state, is able to protect against Aβ toxicity and ameliorate cognitive performance in AD [19–25].